Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Company Info
OncoResponse
Drug Discovery & Development
Overview
0 Contributors
1 / 0
1 / 0
No authors found
1 Contributions
1 / 1
1 / 1
Clinical Trials
OncoResponse to Present Phase 1 Results of Clinical Study of OR502, anti-LILRB2 Antibody, as a Late-Breaker Poster
OncoResponse
PR-10-24-NI-73
Nov 05, 2024
